glp-1 receptor agonist and dpp-4 inhibitor combination not recommended Frontiers | inhibitors for treating T2DM DPP4 Inhibitors vs GLP-1 Agonists

The key strengths of our study are the large, comprehensive source of real-world data available and the robust study design

Like Novo Nordisks Ozempic and Wegovy, both of Eli Lillys tirzepatide drugs are injected on a weekly basis

A large meta-analysis of 64 trials with over 25,500 adults with type 2 diabetes showed that GLP-1s were more effective at reducing A1C levels compared to placebo and traditional diabetes drugs

As the central organ of cholesterol metabolism, the liver directly affects the bodys cholesterol metabolism homeostasis

Safety and efficacy of erenumab for preventive treatment of chronic migraine: A randomised, double-blind, placebo-controlled phase 2 trial